Skip to content

Post Traumatic Critical Complications: a Prospective Cohort Study (ATLANREA)

Prospective Cohort of Severe Trauma Patients Hospitalized in West French Intensive Care Units

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02426255
Enrollment
5000
Registered
2015-04-24
Start date
2013-03-29
Completion date
2050-01-31
Last updated
2022-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Trauma (With or Without Traumatic Brain Injury)

Keywords

Severe trauma, traumatic Brain injury, Hemorrhage

Brief summary

The purpose of this observational epidemiological study is to investigate the management and the complications associated with severe trauma. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.

Detailed description

Pseudonymized data will be collected by study coordinators in a secured e-database. Cross audit will be performed to check data.

Interventions

A code will be applied to each patient included. Medical data such as demography, Simplified Acute Physiological Score II (SAPS II), Sequential Organ Failure Assessment (SOFA), procedures and complications during ICU stay will be collected.

Sponsors

Nantes University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* severe trauma * and/or traumatic brain injury * and/or hemorrhage

Exclusion criteria

* Consent withdrawal

Design outcomes

Primary

MeasureTime frameDescription
in ICU stay complicationsWithin the 28 first days after ICU admission dateNosocomial Infections (epidemiology, risk factors, antibiotic susceptibility of pathogens) Organ failures (incidence, risk factors) Bleeding, hemorrhage Intra-cranial hypertension, brain ischemia Mechanical ventilation weaning, extubation failure

Secondary

MeasureTime frame
Duration of mechanical ventilationin ICU (up to 90 days)
ICU length of stayin ICU (up to 90 days)

Other

MeasureTime frame
Deathin ICU (up to 90 days)

Countries

France

Contacts

Primary ContactKarim Asehnoune, PhD, MD
karim.asehnoune@chu-nantes.fr02 40 08 73 80
Backup ContactAntoine Roquilly, MD
antoine.roquilly@chu-nantes.fr02 40 08 73 80

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026